LBP AM SA

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1970075 Paris, I0

Position in REGN

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$1,873,737

-$179,167 QoQ

Shares Held

3,005

+13.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#529

of 1,322 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LBP AM SA holds $68,103,102 across 9 Biotechnology names. REGN ranks #7 (2.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BNTX	BioNTech SE	388,498	$36,149,738
2	INCY	Incyte Corp	95,697	$10,848,211
3	VRTX	Vertex Pharmaceuticals Inc / Ma	15,597	$7,747,497
4	ALNY	Alnylam Pharmaceuticals, Inc.	14,206	$4,276,432
5	VKTX	Viking Therapeutics, Inc.	93,906	$3,663,273
6	KYMR	Kymera Therapeutics, Inc.	17,947	$2,057,982
7	REGN	Regeneron Pharmaceuticals, Inc. This page	3,005	$1,873,737
8	RPRX	Royalty Pharma plc	22,589	$1,266,565

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,873,737	3,005	+13.1%	Shares	Defined	2026-07-24
2026-03-31	$2,052,904	2,657	-55.6%	Shares	Defined	2026-04-27
2025-12-31	$4,618,097	5,983	-68.3%	Shares	Defined	2026-01-26
2025-09-30	$10,602,162	18,856	+3261.1%	Shares	Defined	2025-10-31
2025-06-30	$294,525	561	0.0%	Shares	Defined	2025-07-18
2025-03-31	$355,803	561	0.0%	Shares	Defined	2025-04-30
2024-12-31	$399,617	561	-1.8%	Shares	Defined	2025-02-10
2024-09-30	$600,258	571	-90.8%	Shares	Defined	2024-11-12
2023-12-31	$5,437,493	6,191	-31.3%	Shares	Sole	2024-02-14
2023-09-30	$7,411,577	9,006	+184.7%	Shares	Sole	2023-11-14
2023-06-30	$2,272,742	3,163	+66.4%	Shares	Sole	2023-08-14
2023-03-31	$1,561,994	1,901	-2.6%	Shares	Sole	2023-05-15
2022-12-31	$1,407,626	1,951	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.